1. An alternative dosing strategy of lenalidomide for patients with relapsed multiple myeloma. (8th August 2014) Authors: Popat, Rakesh; Khan, Iftekhar; Dickson, Jenny; Cheesman, Simon; Smith, Dean; D'Sa, Shirley; Rabin, Neil; Yong, Kwee Journal: British journal of haematology Issue: Volume 168:Number 1(2015:Jan.) Page Start: 148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations. (14th June 2020) Authors: Chavda, Selina J.; Pocock, Rachael; Cheesman, Simon; Lee, Kyung‐Min; Dowling, Emma; Marks, Daniel J. B.; Kyriakou, Charalampia; Lee, Lydia; Sive, Jonathan; Wechalekar, Ashutosh; Rabin, Neil; Yong, Kwee; Popat, Rakesh Journal: British journal of haematology Issue: Volume 190:Number 5(2020) Page Start: e312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Atypical haemolytic uraemic syndrome in the eculizumab era: presentation, response to treatment and evaluation of an eculizumab withdrawal strategy. (27th March 2019) Authors: Neave, Lucy; Gale, Daniel P.; Cheesman, Simon; Shah, Raakhee; Scully, Marie Journal: British journal of haematology Issue: Volume 186:Number 1(2019) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy. (6th August 2019) Authors: Manwani, Richa; Mahmood, Shameem; Sachchithanantham, Sajitha; Lachmann, Helen J.; Gillmore, Julian D.; Yong, Kwee; Rabin, Neil; Popat, Rakesh; Kyriakou, Charalampia; Worthington, Sarah; Sharpley, Faye; Smith, Mark; Shah, Raakhee; Cheesman, Simon; Hawkins, Philip N.; Wechalekar, Ashutosh D. Journal: British journal of haematology Issue: Volume 187:Number 5(2019) Page Start: 638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparison of Rituximab originator (MabThera) to biosimilar (Truxima) in patients with immune‐mediated thrombotic thrombocytopenic purpura. (28th March 2019) Authors: Stubbs, Matthew J.; Low, Ryan; McGuckin, Siobhan; Newton, Rosalind; Thomas, Mari; Westwood, John P.; Shah, Raakhee; Cheesman, Simon; Scully, Marie A. Journal: British journal of haematology Issue: Volume 185:Number 5(2019) Page Start: 912 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DT‐PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation. (25th November 2020) Authors: Ainley, Louise; Chavda, Selina J.; Counsell, Nicholas; Cheesman, Simon; Newrick, Fiona; Horder, Jackie; Kyriakou, Charalampia; Papanikolaou, Xenofon; Sive, Jonathan; Lee, Lydia; Wechalekar, Ashutosh; Mehta, Atul; Popat, Rakesh; Rabin, Neil; Yong, Kwee Journal: British journal of haematology Issue: Volume 192:Number 3(2021) Page Start: e73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Introduction of Biosimilar Rituximab: A Hospital Perspective. Issue 1 (9th January 2021) Authors: Cheesman, Simon Journal: HemaSphere Issue: Volume 5:Issue 1(2021) Page Start: e515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma: impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set. Issue 5 (16th April 2021) Authors: Ziff, Monica; Lawson, Gabrielle; De-Silva, Dunnya; Cheesman, Simon; Kyriakou, Charalampia; Mahmood, Shameem; Papanikolaou, Xenofon; Rabin, Neil; Sachchithananthan, Sajitha; Sive, Jonathan; Wechalekar, Ashutosh; Yong, Kwee; Popat, Rakesh Journal: Leukemia & lymphoma Issue: Volume 62:Issue 5(2021) Page Start: 1243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis. (2nd July 2020) Authors: Cohen, Oliver C.; Brodermann, Maximillian H.; Blakeney, Iona J.; Mahmood, Shameem; Sachchithanantham, Sajitha; Ravichandran, Sriram; Law, Steven; Lachmann, Helen J.; Whelan, Carol J.; Popat, Rakesh; Rabin, Neil; Yong, Kwee; Kyriakou, Charalampia; Shah, Raakhee; Cheesman, Simon; Worthington, Sarah... Journal: Amyloid Issue: Volume 27:Number 3(2020) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Real world experience of bortezomib re‐treatment for patients with multiple myeloma at first relapse. (8th April 2016) Authors: Reyal, Yasmin; Popat, Rakesh; Cheesman, Simon; Rismani, Ali; D'Sa, Shirley; Rabin, Neil; Yong, Kwee Journal: British journal of haematology Issue: Volume 177:Number 3(2017) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗